Access the full text.
Sign up today, get DeepDyve free for 14 days.
K Gouda, U Das, G Dhangadamajhi (2021 Oct)
Utility of Fine Needle Aspiration Cytology (FNAC) in the diagnosis of tuberculous lymphadenitis compared to GeneXpert in a tertiary health care center in Northern Odisha, India, 68
P Patro, P Lad, MB Hoogar, R Dhar, S Sahu, KB Mithila (2018)
Spectrum of lesions in lymph nodes-a cytological study, 8
MJ Swaroopa, B Vani (2019)
Study of cytomorphological patterns of lymph nodes by fine needle aspiration cytology and correlation with histopathology, 4
MA Al-Abbadi, H Barroca, B Bode-Lesniewska, M Calaminici, NP Caraway, DF Chhieng (2020)
A proposal for the performance, classification, and reporting of lymph node fine-needle aspiration cytopathology: the Sydney system, 64
M Jin, PE Wakely (2018)
Lymph node cytopathology: essential ancillary studies as applied to lymphoproliferative neoplasms, 126
CW Michael, K Kameyama, W Kitagawa, N Azar (2020)
Rapid on-site evaluation (ROSE) for fine needle aspiration of thyroid: benefits, challenges and innovative solutions, 9
M Rakhshan, A Rakhshan (2009)
The diagnostic accuracy of fine needle aspiration cytology in neck lymphoid masses, 4
SM Choi, AR Lee, JY Choe, JS Nam, DH Chung, J Lee (2016)
Adequacy criteria of rapid on-site evaluation for endobronchial ultrasound-guided Transbronchial needle aspiration: a simple algorithm to assess the adequacy of ROSE, 01
C Mathiot, D Decaudin, J Klijanienko, J Couturier, A Salomon, J Dumont (2006)
Fine-needle aspiration cytology combined with flow cytometry immunophenotyping is a rapid and accurate approach for the evaluation of suspicious superficial lymphoid lesions, 34
E Vigliar, G Acanfora, A Iaccarino, M Mascolo, D Russo, G Scalia (2021 Jul 21)
A novel approach to classification and reporting of lymph node fine-needle cytology: application of the proposed Sydney system, 11
N Agrawal, K Kothari, S Tummidi, P Sood, M Agnihotri, V Shah (2021)
Fine-needle aspiration biopsy cytopathology of breast lesions using the international academy of cytology yokohama system and rapid on-site evaluation: a single-institute experience, 65
P Zeppa, I Cozzolino (2018)
Historical background, clinical applications, controversies, 23
M Ali, G Rizvi, A Kaushik (2020 Jul 1)
Cytological evaluation of enlarged peripheral lymph nodes: an institutional experience from kumaon region of Uttarakhand, 7
K Kothari, S Tummidi, M Agnihotri, P Sathe, L Naik (2019 Dec)
This ?rose? has no thorns-diagnostic utility of ?rapid on-site evaluation? (ROSE) in fine needle aspiration cytology, 10
S Tummidi, A Shankaralingappa, V Sharmila (2022)
Applicability of on-site evaluation of cervical cytology smears stained with toluidine blue to reduce unsatisfactory results, 66
RK Chaurasia, P Sharma (2019)
A cytological study of pattern of lymph node lesions at tertiary care centre in Uttar Pradesh, 6
K Florence, K Suresh, K Lavanya (2018)
Cytopathological study of lymph node lesions?A 2 years retrospective study
A Hemalatha, PS Shruti, MU Kumar, A Bhaskaran (2014)
Cytomorphological patterns of tubercular lymphadenitis revisited, 4
B Anand, A Mariaselvam (2020)
Cytomorphology of lymphadenopathy with a report on patterns of tuberculous lymphadenitis in a resource-limited setting, 6
A Caputo, V Ciliberti, A D’Antonio, A D’Ardia, R Fumo, V Giudice (2022 Mar)
Real-world experience with the Sydney System on 1458 cases of lymph node fine needle aspiration cytology, 33
S Ahuja, A Malviya (2022)
Categorisation of lymph node aspirates using the proposed Sydney system with assessment of risk of malignancy and diagnostic accuracy, 33
A Ronchi, A Caputo, F Pagliuca, M Montella, FZ Marino, P Zeppa (2021)
Lymph node fine needle aspiration cytology (FNAC) in pediatric patients: why not? Diagnostic accuracy of FNAC in a series of heterogeneous paediatric lymphadenopathies, 217
P Gupta, N Gupta, P Kumar, S Bhardwaj, R Srinivasan, P Dey (2021 Apr 8)
Assessment of risk of malignancy by application of the proposed Sydney system for classification and reporting lymph node cytopathology, 129
TEA Miller, D Shelton, DN Rana, N Narine (2017)
Angioimmunoblastic T cell lymphoma mimics reactive lymphoid tissue on cytomorphology: a multimodality approach utilising cytology, immunocytochemistry and flow cytometry to resolve this diagnostic dilemma, 28
P Zeppa, I Cozzolino, NP Caraway, MA Al-Abbadi, H Barroca, B Bode-Lesniewska (2020)
Announcement: the international system for reporting lymph node cytopathology, 64
E Uzun, S Erkilic (2022 May)
Diagnostic accuracy of Thinprep� in cervical lymph node aspiration: assessment according to the Sydney system, 50
VV Makarenko, ME DeLelys, RP Hasserjian, A Ly (2022 Feb)
Lymph node FNA cytology: diagnostic performance and clinical implications of proposed diagnostic categories, 130
NH Hafez, NS Tahoun (2011 Sep 1)
Reliability of fine needle aspiration cytology (FNAC) as a diagnostic tool in cases of cervical lymphadenopathy, 23
Introduction: Fine-needle aspiration cytology (FNAC) is an established first-line technique for the evaluation of lymphadenopathy and, with the help of ancillary testing, can in many instances obviate the need for an open biopsy. The Sydney system was recently proposed to provide consensus guidelines for the performance, classification, and reporting of lymph node FNAC. The present study was undertaken to evaluate its utility and study the impact of rapid on-site evaluation (ROSE). Material and Methods: A retrospective analysis in which 1,500 lymph node FNACs was reviewed and assigned a diagnostic category from the Sydney system. Cyto-histopathological correlation and adequacy parameters were evaluated. Observation and Results: The cervical group of lymph nodes was the commonest group aspirated (89.7%). A total of 1,205/1,500 (80.3%) cases were category II (benign), and necrotizing granulomatous lymphadenitis was the most common pathology. The 750 cases with ROSE were subclassified as follows: 15 category I (inadequate), 629 category II (benign), 2 category III (atypia of undetermined significance), 9 category IV (suspicious for malignancy), and 95 category V (malignant). Among 750 cases without ROSE, 75 cases were in category I, 576 in category II, 3 in category III, 6 in category IV, and 90 in category V. Category I was thus significantly lower in the ROSE group compared to the non-ROSE group. Overall, the risk of malignancy was L1-0%, L2-0.20%, L3-100%, L4-92.3%, and L5-100%. Accuracy parameters revealed a sensitivity of 97.7%, specificity of 100%, PPV of 100%, NPV of 99.10%, and diagnostic accuracy of 99.54%. Discussion and Conclusion: FNAC can be used as the 1st line of treatment for lymph node pathology. ROSE can be used as an add-on to FNAC for reducing unsatisfactory rates and help triage material for ancillary testing whenever possible. The Sydney system should be implemented for achieving uniformity and reproducibility.
Acta Cytologica – Karger
Published: Oct 1, 2023
Keywords: Lymph node; Cytology; Sydney; Rapid on-site evaluation; Toluidine blue; Histopathology
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.